During the coronavirus pandemic, many U.S. locales deemed cannabis an essential item, and the resultant surge in sales brought revenue pouring in for several marijuana companies. Sequential growth from the prior quarter, however, was a mere 2%, and revenue from the Canadian recreational market sank 11% to CA$44.2 million, challenged by the pandemic-era retail operating environment. Read More...
Better Marijuana Stock: Canopy Growth vs. Aphria
During the coronavirus pandemic, many U.S. locales deemed cannabis an essential item, and the resultant surge in sales brought revenue pouring in for several marijuana companies. Sequential growth from the prior quarter, however, was a mere 2%, and revenue from the Canadian recreational market sank 11% to CA$44.2 million, challenged by the pandemic-era retail operating environment.
Add Comment